1. Home
  2. ASG vs TNXP Comparison

ASG vs TNXP Comparison

Compare ASG & TNXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ASG
  • TNXP
  • Stock Information
  • Founded
  • ASG 1986
  • TNXP 2007
  • Country
  • ASG United States
  • TNXP United States
  • Employees
  • ASG N/A
  • TNXP N/A
  • Industry
  • ASG Investment Managers
  • TNXP Biotechnology: Pharmaceutical Preparations
  • Sector
  • ASG Finance
  • TNXP Health Care
  • Exchange
  • ASG Nasdaq
  • TNXP Nasdaq
  • Market Cap
  • ASG 327.8M
  • TNXP 335.6M
  • IPO Year
  • ASG N/A
  • TNXP N/A
  • Fundamental
  • Price
  • ASG $5.49
  • TNXP $37.98
  • Analyst Decision
  • ASG
  • TNXP Buy
  • Analyst Count
  • ASG 0
  • TNXP 1
  • Target Price
  • ASG N/A
  • TNXP $70.00
  • AVG Volume (30 Days)
  • ASG 324.3K
  • TNXP 2.2M
  • Earning Date
  • ASG 01-01-0001
  • TNXP 08-11-2025
  • Dividend Yield
  • ASG 8.09%
  • TNXP N/A
  • EPS Growth
  • ASG N/A
  • TNXP N/A
  • EPS
  • ASG N/A
  • TNXP N/A
  • Revenue
  • ASG N/A
  • TNXP $9,831,000.00
  • Revenue This Year
  • ASG N/A
  • TNXP $22.87
  • Revenue Next Year
  • ASG N/A
  • TNXP $711.66
  • P/E Ratio
  • ASG N/A
  • TNXP N/A
  • Revenue Growth
  • ASG N/A
  • TNXP N/A
  • 52 Week Low
  • ASG $4.47
  • TNXP $6.76
  • 52 Week High
  • ASG $5.71
  • TNXP $130.00
  • Technical
  • Relative Strength Index (RSI)
  • ASG 53.88
  • TNXP 43.12
  • Support Level
  • ASG $5.36
  • TNXP $34.50
  • Resistance Level
  • ASG $5.51
  • TNXP $53.55
  • Average True Range (ATR)
  • ASG 0.06
  • TNXP 6.41
  • MACD
  • ASG -0.01
  • TNXP -1.97
  • Stochastic Oscillator
  • ASG 81.25
  • TNXP 11.06

About ASG Liberty All-Star Growth Fund Inc.

Liberty All Star Growth Fund Inc is the United States based diversified, closed-end management investment company. Its investment objective is to seek long-term capital appreciation through investment in a diversified portfolio of equity securities. The company portfolio of investments consists of different industries such as consumer discretionary, consumer staples, healthcare, industrial, information technology and others.

About TNXP Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering. Tonix's development portfolio is focused on central nervous system (CNS) disorders. The company's immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (CD40L or CD154) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. Tonix also has product candidates in development in the areas of rare disease and infectious disease.

Share on Social Networks: